2 completed. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 2 |
Follow CD5024: new trials by email Literature Review of CD5024 trials Research Report on CD5024
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase 3 Papulopustular Rosacea Study CD5024, Azelaic acid 15% Gel - Papulopustular Rosacea | Phase 3 | Completed | Galderma R&D | 688 | 2011-12-01 | 2021-02-18 |
| Phase 3 Papulopustular Rosacea Study CD5024, Azelaic acid 15% Gel - Papulopustular Rosacea (PPR) | Phase 3 | Completed | Galderma R&D | 683 | 2011-12-01 | 2021-02-18 |
Rosacea (2)
Galderma R&D (2)
Canada (2) · United States (2)